Analyst Coverage
New Forrester Report titled:
Pharma Risk Managers: ERM Is In Your Future.
Register to Download Your Free Copy (PDF)
EXECUTIVE SUMMARY
Pharma risk managers and compliance professionals face increasing regulatory scrutiny and market pressures that amplify both business and operational risk. To keep from drowning under a rising tide of agency mandates, legal precedents, and financial controls, pharma must abandon its reactive, functional approach to risk mitigation in favor of a more proactive and structured enterprise risk management (ERM) response.
Software Providers Deliver Key ERM Components
Where compliance was once managed with spreadsheets, documents, and homegrown applications, software platforms have emerged that drive value through consistent collection and processing of compliance information. Key software providers stand ready to help pharma firms build governance, risk, and compliance (GRC) processes and the supporting technology platforms needed to efficiently detect and deter risks, driving top-line business performance improvements through widely applied risk management processes.
Pharma firms should select vendors according to how well they fill identified gaps in ERM functionality requirements. Those firms focused on obtaining a core GRC system will find that QUMAS offers the breadth of GRC capabilities across the pharma life cycle today.